DXCM Q4 2019 Earnings — DexCom, Inc. Revenue & Financial Results | Market Cap Arena

DXCMDexCom, Inc.

$26B

Q4 2019 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$463M+36.9% YoY

Gross Profit

$309M66.8% margin

Operating Income

$102M21.9% margin

Net Income

$93M20.0% margin

EPS (Diluted)

$0.25

QoQ Revenue Growth

+16.8%

Cash Flow

Operating Cash Flow

$144M

Free Cash Flow

$100M

Stock-Based Comp.

$24M

Balance Sheet

Total Assets

$2.4B

Total Liabilities

$1.5B

Stockholders' Equity

$883M

Cash & Equivalents

$446M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$463M	$338M	+36.9%
Gross Profit	$309M	$223M	+38.8%
Operating Income	$102M	-$165M	+161.7%
Net Income	$93M	-$180M	+151.6%

Geographic Segments

UNITED STATES

$376M81%

Non-US

$87M19%